Latest filing published 24 May 2016 for Achieve Life Sciences, INC..
Insider track record
No signal scores available.
Neil James Clendeninn: trading record in brief
Neil James Clendeninn discloses dealings in Achieve Life Sciences, Inc. to SEC (Form 4). Between 1 July 2011 and 20 May 2016, the trades on record add up to 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 24 May 2016 came the latest disclosure, an option exercise in Achieve Life Sciences, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Neil James Clendeninn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 sharesCommon StockSEC:0001209191-16-122825:0
- 5,359 shares@ US$2.69Common StockSEC:0001209191-15-077353:0
- 2,500 sharesCommon StockSEC:0001209191-15-045785:0
- 2,500 sharesCommon StockSEC:0001209191-14-039792:0
- 513 shares@ US$4.11Common StockSEC:0001209191-12-050018:0
- 3,702 shares@ US$4.11Common StockSEC:0001209191-12-040805:0
- 3,347 shares@ US$3.89Common StockSEC:0001209191-11-038162:0
7 of 7 declarations